Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Exercise/Conversion of 37,500 TVTX shares, $579.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 37,500 | $579.8K |
| May 7, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 20,000 | $359.2K |
| Apr 16, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 14,000 | n/a |
| Apr 2, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 10,000 | $154.6K |
| Mar 18, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 10,000 | $190.8K |
| Feb 19, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 10,000 | $190.8K |
| Feb 5, 2026 | Travere Therapeutics, Inc. (TVTX) | Sale | 2,485 | $79.7K |
| Feb 4, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 25,110 | n/a |
| Jan 21, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 10,000 | $190.8K |
| Sep 24, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 10,000 | $190.8K |